26.82
-0.28
(-1.03%)
As of 2:06:26 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-14,772.00
-18,158.00
-12,879.00
22,678.00
10,092.00
Investing Cash Flow
13,683.00
-711.00
-20,221.00
-26,500.00
-209.00
Financing Cash Flow
114,433.00
120,593.00
-4,451.00
12,835.00
19,793.00
End Cash Position
146,816.00
159,550.00
57,826.00
95,377.00
86,364.00
Income Tax Paid Supplemental Data
--
--
76.00
--
--
Interest Paid Supplemental Data
--
--
--
311.00
692.00
Capital Expenditure
--
-17.00
-15,247.00
-26,500.00
-1,209.00
Issuance of Capital Stock
--
--
--
40,000.00
24,600.00
Issuance of Debt
--
130,000.00
--
--
--
Repayment of Debt
--
--
--
-4,250.00
-5,313.00
Free Cash Flow
-14,806.00
-18,175.00
-28,126.00
-3,822.00
8,883.00
12/31/2020 - 6/6/1986
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SYRE Spyre Therapeutics, Inc.
23.27
-0.02%
WPDPF WPD Pharmaceuticals Inc.
0.0000
0.00%
HSTOQ Histogen Inc.
0.0287
0.00%
PHGUF Pharming Group N.V.
0.8690
0.00%
ISCO International Stem Cell Corporation
0.1050
+16.67%
MIRM Mirum Pharmaceuticals, Inc.
50.61
-0.23%
ELDN Eledon Pharmaceuticals, Inc.
4.4500
-1.11%
ALZ.ST Alzinova AB (publ)
3.0400
+1.33%
J90.F NurExone Biologic Inc.
0.4440
+11.56%
CDTX Cidara Therapeutics, Inc.
24.12
+2.79%